Separate commercial, limited, prototype and development stages.
Robot product dossier · 10
da Vinci 5
Intuitive · Regulated markets / United States and Europe · Robotic-assisted surgery
Commercial / operationalRegulated commercial surgical system; authorisation and indications vary by jurisdictionLast reviewed: 11 August 2026
Decision questionHow should hospitals evaluate a surgical platform beyond regulatory authorisation and headline features?
10
FUURAA thesis
da Vinci 5 is a clinician-operated surgical platform, not an autonomous surgeon. Decisions must combine applicable authorisation, procedure evidence, training, service, cybersecurity and hospital-level outcomes.
Reading method
Do not ask only what the robot can do; ask how the whole system works, fails and recovers.
Inventory software, payloads, facilities and people beyond the robot.
Move from demos to repeated tests, field data and auditable records.
State what first-party reporting still cannot prove.
System and workflow map
Four interdependent layers turn a product name into real operating conditions.
Each layer explains its role and what procurement, research or deployment teams should watch.
Surgeon console
The clinician remains responsible for directing instrument movement.
Patient-side system
Robotic arms and instruments translate commands at the operative field.
Clinical workflow
Outcomes depend on team training, case selection and perioperative processes.
Governance
Regulatory scope, maintenance, data protection and incident reporting constrain use.
Decision checklist
Five checks turn product interest into verifiable procurement, research or pilot questions.
Define the task, interfaces, safety and operations before requesting evidence that supports a decision.
- 01
Task fit
Define procedures, patient selection, comparative pathway and expected benefit.
- 02
Integration load
Plan operating-room layout, sterilisation, instruments, imaging, IT and service.
- 03
Safety case
Use applicable regulatory labelling, clinical governance and emergency conversion protocols.
- 04
Operating model
Model team training, credentialing, utilisation, consumables and downtime.
- 05
Evidence to request
Request procedure-specific outcomes, complications, learning-curve and total-cost evidence.
Scope boundaries
Product availability, a video demonstration or a commercial agreement each supports only bounded conclusions.
- 01
Regulatory authorisation does not mean superiority for every patient or procedure.
- 02
The system assists clinician-controlled surgery; it is not autonomous surgery.
- 03
CE marking and other authorisations have jurisdiction- and indication-specific scope.
Sources and evidence status
Primary product material and independent evaluation context are kept distinct.
Dates, source identity, supported conclusions and reading boundaries remain reviewable.
01
Intuitive · 2025-07-02
↗02da Vinci 5 — official product or programme source
A fifth-generation multiport robotic-assisted surgical system with market-specific regulatory authorisations.
U.S. Food and Drug Administration · Accessed 2026-08-11
↗Computer-assisted surgical systems
Supporting material used to calibrate evaluation method and scope boundaries.